FREQ | tickerfilter.com

Fundamental analysis

14%

Profitability 3%

Dept financing 38%

Liquidity 41%

Performance 12%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

2.53%

6 Months

-23.48%

1 Year

-23.48%

2 Year

1,275.68%

Key data

Stock price

$0.32

P/E Ratio

0.00

DAY RANGE

N/A - N/A

EPS

$0.00

52 WEEK RANGE

$33.31 - $52.69

52 WEEK CHANGE

-$23.48

MARKET CAP

10.942 M

YIELD

N/A

SHARES OUTSTANDING

36.521 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.47

PUBLIC FLOAT

AVERAGE 10 VOLUME

N/A

AVERAGE 30 VOLUME

N/A

Company detail

CEO:
Region: US
Website: frequencytx.com
Employees: 66
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.

FREQ - Korro Bio Inc.